Found 314 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma PHASE2 This study will address the question of whether targeting CMV antigens with...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
The Addition of Temozolomide to Conditioning for Autologous Transplantation in Relapsed & Refractory CNS Lymphoma PHASE2 The primary purpose of the study will be testing the dosing of temozolomide...
Show More Location
Cedars Sinai Medical Center
Learn More & Join Trial
GRETeL: Tumor Response to Standard Radiotherapy and TMZ Patients With GBM N/A The purpose of this study is to better define longitudinal genomic alterati...
Show More Location
The Preston Robert Tisch Brain Tumor Center at Duke University
Learn More & Join Trial
A Dose Finding Study of [177Lu]Lu-DOTA-TATE in Newly Diagnosed Glioblastoma in Combination With Standard of Care and in Recurrent Glioblastoma as a Single Agent. PHASE1 A Dose Finding Study of \[177Lu\]Lu-DOTA-TATE in Newly Diagnosed Glioblasto...
Show More Status
Active Not Recruiting
Location
Col Uni Med Center New York Presby
Learn More & Join Trial
Survivin-Targeted Dendritic Cell (DC) Cell Injection for Newly Diagnosed Glioblastoma PHASE2 The overall objective of this study is to preliminarily evaluate the effica...
Show More Location
Multiple Locations
Learn More & Join Trial
Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma PHASE1 The early clinical development paradigm for chemotherapeutic agents has sig...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
LAM561 With RT and TMZ for Adults With Glioblastoma PHASE2 The proposed Phase IIB/III randomized, double-blind, placebo-controlled tri...
Show More Status
Active Not Recruiting
Location
Institut Cancerologie de L'Ouest (ICO)
Learn More & Join Trial
A Study of BBI608 in Combination With Temozolomide in Adult Patients With Recurrent or Progressed Glioblastoma PHASE1 This is an open label, multi-center, phase 1 safety run-in and phase 2 stud...
Show More Location
Laura and Isaac Perlmutter Cancer Center
Learn More & Join Trial
Whole Brain Radiation Therapy With Standard Temozolomide Chemo-Radiotherapy and Plerixafor in Treating Patients With Glioblastoma PHASE2 This phase II trial studies how well whole brain radiation therapy works wi...
Show More Location
Stanford Cancer Institute Palo Alto
Learn More & Join Trial
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma PHASE2 RATIONALE: Drugs used in chemotherapy, such as temozolomide, work in differ...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial